| 产品编号 | bs-0437P-PE |
| 英文名称 | Streptavidin |
| 中文名称 | PE标记链霉亲和素 |
| 别 名 | SA V1; SA V2; Streptavidin V1; Streptavidin V2; SA; Streptavidin/PE; Streptavidin PE; Streptavidin-PE; Streptavidin(PE); PE conjugated Streptavidin. 链霉抗生物素蛋白; 链霉卵白素; 9013-20-1; |
 |
Specific References (2) | bs-0437P-PE has been referenced in 2 publications.
[IF=3.647] Yao Ma. et al. Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment. Life Sci. 2020 Dec;262:118565
[IF=3.375] Yun Liu. et al. Synergistic anti-tumor effect of anti-PD-L1 antibody cationic microbubbles for delivery of the miR-34a gene combined with ultrasound on cervical carcinoma. Am J Transl Res. 2021; 13(3): 988–1005 Other ;
|
| 理论分子量 | kDa |
| 检测分子量 | |
| 性 状 | Liquid |
| 浓 度 | 1mg/ml |
| 物 种 | Streptomyces |
| 序 列 | 1-183/183 |
| 纯 度 | >90% as determined by SDS-PAGE |
| 纯化方法 | AC |
| 内毒素 | Not analyzed |
| 表达系统 | N/A |
| 活性 | Yes |
| 标签 | Tag free |
| 缓 冲 液 | 10 mM TBS (pH=7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存条件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
Streptavidin is a tetrameric protein composed of identic subunits. Each subunit binds one biotin molecule with a KD of ~1x10-15M. The preparation contains an N- and C-terminal shortened variant (core streptavidin) with improved properties concerning homogeneity, solubility, resistance towards proteolytic degradation and accessibility of the biotin binding pocket as compared to native streptavidin. The high affinity recognition of biotin and biotinylated molecules has made streptavidin one of the most important components in diagnostics and laboratory kits. |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
